A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1

Clinical trial NCT01373606 · COMPLETED

Trial details

NCT number: NCT01373606
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatorenal Syndrome Type 1

Start date: 2007-11-01
Primary completion: 2009-03-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.